Disability Benefits for Thrombocytopenia

How SSA Evaluates Thrombocytopenia

Thrombocytopenia is an abnormally low platelet count. Platelets are the blood cells that form clots, so when they run low the body bruises easily and bleeds — from the gums and nose, into the skin, and, in severe cases, internally. The Social Security Administration evaluates it under Blue Book listing 7.08, disorders of thrombosis and hemostasis, which covers conditions that cause either dangerous bleeding or dangerous clotting.

Listing 7.08 is met when your disorder causes:

• Repeated complications of hemostasis — spontaneous, serious bleeding or clotting episodes — requiring hospitalization or transfusion of blood products on average at least three times in a five-month period, roughly once every six weeks.

Thrombocytopenia has many causes, including immune thrombocytopenia (ITP), bone marrow disorders, chemotherapy, liver disease, and certain medications. SSA considers the underlying cause and, where the low platelets are part of a broader blood disorder or bone marrow failure, may also evaluate the claim under related listings such as 7.10 or 7.18. Very low counts are medically urgent because of the risk of spontaneous bleeding in the brain or gut, so records showing dangerously low platelets and bleeding events are central. As with all listings, the impairment must last, or be expected to last, at least 12 months.

Medical Evidence SSA Needs for Thrombocytopenia

SSA needs laboratory documentation of the low platelet counts over time — complete blood counts showing how far and how persistently the platelets fall — together with the diagnostic workup that explains the cause, which may include a bone marrow examination, antibody testing, or liver studies.

Because the listing turns on serious bleeding events, records of those episodes are the most important evidence: emergency room and hospital records for bleeding, transfusion dates for platelets or other blood products, and documentation of any internal bleeding. The frequency of these events is what establishes whether listing 7.08 is met.

Also document the treatments tried — steroids, immunoglobulin, other immune therapies, splenectomy, or medications that raise platelet counts — and your response, along with side effects. Hematology notes summarizing the course of the disease complete the record.

Qualifying Through Your Residual Functional Capacity

When bleeding episodes are serious but not quite as frequent as listing 7.08 requires, the residual functional capacity analysis often carries the claim. A persistently low platelet count creates a real bleeding risk that must be built into your work restrictions: no hazardous machinery, no work at heights, and avoidance of jobs where cuts, bruising, or falls are likely, because a minor injury can become a major bleed. Many claimants are advised to avoid even moderately strenuous or contact activity.

Beyond the safety limits, the fatigue that often accompanies low counts and any underlying blood disorder reduces stamina and sustained work capacity. Unpredictable bleeding episodes, hospitalizations, and frequent lab monitoring translate into absences and off-task time that competitive employers do not tolerate.

For claimants 50 and older, a sedentary RFC with these limitations and the medical-vocational grid rules can lead to approval. Younger claimants generally need to show that bleeding risk, fatigue, and unpredictable absences make sustained work unfeasible even in a low-exertion job.

Tips for a Stronger Thrombocytopenia Claim

Because the listing depends on documented bleeding events, careful records make the difference.

• Keep track of every bleeding episode, transfusion, and hospitalization with dates — the frequency is what satisfies listing 7.08.
• Save all platelet counts so SSA can see how low and how sustained they are.
• Have any activity restrictions your doctor recommends — avoiding injury risk, heavy exertion, or hazards — written into your record.
• Document treatment side effects, especially from steroids and immune therapies, which can be limiting on their own.
• Ask your blood doctor to explain the bleeding risk in functional terms an adjudicator can apply to a workplace.